Source: FactSet Fundamentals. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights... Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. All rights reserved. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of Acasti to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Past success does not guarantee future profit !! Sign-up for continuing coverage on shares of ACST stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick! Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. *Stock price forecasts are predicted by Deep Learning processes by technical analysis, shouldn't been used for investment decision. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels. You can change your choices at any time by visiting Your Privacy Controls. ACST's 51 means that it ranks higher than 51% of stocks. Portfolio results are unaudited and based on varying investment expiration dates. To add more color to this target, the company’s high over the last year is $3.08 and the low is $0.18. During the day, the stock rose to $0.24 and sunk to … Contact: Crescendo Communications, LLC Tel: 212-671-1020 Email: ACST@crescendo-ir.com, Here's Why We're Watching Prime Mining's (CVE:PRYM) Cash Burn Situation, Here's Why We're A Bit Worried About Axovant Gene Therapies' (NASDAQ:AXGT) Cash Burn Situation, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqCM - NasdaqCM Real Time Price. - Apis Global Long/Short Equity Fund, Series Portfolios Trust - Weiss Alternative Balanced Risk Fund. Acasti Pharma Inc. ACST also noted assets of $20.14 million at the end of the last quarter. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Disclosure: we hold no position in ACST, either long or short, and we have not been compensated for this article. View the real-time ACST price chart on Robinhood and decide if you want to buy or sell commission-free. As of 2020 November 12, Thursday current price of ACST stock is 0.211$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). Find out when ACST reaches critical levels. 1 day left to get our exclusive 11.11 promo! ACST has seen increased volume after this news and investors are putting their support behind the value proposition. Data may be intentionally delayed pursuant to supplier requirements. All rights reserved. ACST is increasing its credibility in this sector and that could lead to more upside down the line. Find the latest Acasti Pharma, Inc. (ACST) stock quote, history, news and other vital information to help you with your stock trading and investing. Find out more about how we use your information in our Privacy Policy and Cookie Policy. Source: Kantar Media, Amarin Stock Is Surging as Rivals’ Fish-Oil Heart Drugs Fail, Acasti Pharma Shares Plunge After CaPre Phase 3 Study Failure, Acasti Pharma Shares Down 74% After Missing Primary Endpoint, Acasti Pharma Shares Drop 54% on Disappointing Trial Results, Acasti Pharma Announces the Election of Its Directors, Advisory Resolution Approving Compensation, Amendments to Its Stock Option and Equity Incentive Plans, Adoption of Amended & Restated General By-Law and Other Related Matters Approved at Its AGM, Acasti Announces Review Process of Strategic Alternatives, Acasti Appoints Seasoned Executive Brian D. Ford CPA-CA as Chief Financial Officer, Acasti Announces Filing and Mailing of Information Circular and Change in Record Date, Acasti Pharma Reports Topline Triglyceride Results from Phase 3 TRILOGY 2 Study of CaPre in Patients with Severe Hypertriglyceridemia, Alma Capital Invt. What this means: Acasti Pharma (ACST) gets an Overall Rank of 51, which is an above average rank under InvestorsObserver's stock ranking system. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.The forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement, the “Special Note Regarding Forward-Looking Statements” section contained in Acasti’s latest annual report on Form 10-K and latest quarterly report on Form 10-Q, which are available on SEDAR at www.sedar.com, on EDGAR at www.sec.gov/edgar/shtml, and on the investor section of Acasti’s website at www.acastipharma.com. HEXO Corp. (NYSE:HEXO) is Gaining Momentum on Earnings Catalyst, Is the Rough Ride Over for Tencent Music Entertainment Group (TME). Copyright 2020© FactSet Research Systems Inc. All rights reserved. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. All told, Acasti Pharma Inc. ACST has strung together solid data and demonstrated underlying fundamentals. The Company is developing CaPre in a Phase 3 clinical program in patients with severe hypertriglyceridemia. View today's stock price, news and analysis for Acasti Pharma Inc. (ACST). ACST has a short ratio of 0.32 and outstanding shares of 96.87M. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below. Acasti Pharma Stock Loses a Wall Street Supporter. Acasti Pharma, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. The forward-looking statements contained herein are also subject generally to assumptions and risks and uncertainties that are described from time to time in Acasti’s public securities filings with the Securities and Exchange Commission and the Canadian securities commissions, including Acasti’s latest annual report on Form 10-K under the caption “Risk Factors”.Neither NASDAQ, the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Acasti Contact: Jan D’Alvise Chief Executive Officer Tel: 450-686-4555 Email: info@acastipharma.com www.acastipharma.comU.S. Acasti does not undertake to update any such forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. As of 2020 October 31, Saturday current price of ACST stock is 0.192$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). All Rights Reserved. Share your opinion and gain insight from other stock traders and investors. To add more color to this... Air Lease Corporation (AL) shares are trading at lower $33.83 and the avg recommendation for the stock is Strong Buy, while the current analyst... Chevron Corporation (CVX) shares are trading at lower $82.46 and the avg recommendation for the stock is Moderate Buy, while the current analyst price... Li Auto Inc. (LI) shares are trading at lower $24.97 and the avg recommendation for the stock is Strong Buy, while the current analyst... Pinduoduo Inc. (PDD) shares are trading at higher $111.46 and the avg recommendation for the stock is Moderate Buy, while the current analyst price... HEXO Corp. (HEXO) shares are trading at lower $0.78.

Vegan Eyeshadow Singles, Torani Promo Code July 2020, Sausage And Gnocchi Casserole, Guardian Dental Advantage Silver, Samsung S20 Ultra Specs, Best White Papers 2018,